カンナビノイド受容体-Gi複合構造による活性化およびシグナル伝達機構
Tian Hua1, Xiaoting Li1, Lijie Wu1
1iHuman Institute, ShanghaiTech University, Shanghai 201210, China.
Cell
|February 1, 2020
まとめ
カナビノイド受容体CB1とCB2の構造的な洞察は,多様な活性化メカニズムを明らかにします. この研究は,CB1に関連した精神活性のない痛みを和らげる選択的なCB2アゴニストの開発への道を開きます.
科学分野:
- 生物化学
- 構造生物学
- 薬理学について
背景:
- 人間のエンドカンナビノイド系は,カンナビノイド受容体CB1とCB2を含むもので,生理学的プロセスを調節する.
- CB1とCB2に対する構造情報と低アゴニスト選択性は,特にCB1の精神活性のない痛みを標的とするCB2選択薬の治療用途を阻害しています.
研究 の 目的:
- 合成アゴニストとGiと結合するカンナビノイド受容体の構造を決定する.
- CB2選択的アゴニスト設計の構造的基礎を明らかにする.
- カナビノイド受容体の調節におけるコレステロールの役割を調査する.
主な方法:
- 合成カンナビノイド結合CB1とCB2の構造を決定するために,冷凍電子顕微鏡 (cryo-EM) を使用した.
- アゴニスト結合CB2の構造を得るためにX線結晶学を用いた.
主要な成果:
- この研究は,CB1およびCB2受容体の多様な活性化およびシグナル伝達メカニズムを明らかにしています.
- 新しい構造的な洞察は,CB2選択的アゴニストの設計のための基礎を提供します.
- コレステロールとCB1の間の予期せぬ相互作用は,コレステロールの潜在的内生性アロステリック調節作用を示唆する.
結論:
- 決定された構造は,カンナビノイド受容体の機能と活性化に関する重要な洞察を提供します.
- この研究は,炎症性および神経疾患の痛みに対する CB2受容体を標的とした新しい治療法を開発するための構造的基盤を提供します.
- コレステロールとCB1の相互作用の発見は,エンドカンナビノイドシステムの調節を理解するための新しい道を開きます.
さらに関連する動画
関連する概念動画
Activation and Inactivation of G Proteins
9.1K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
9.1K
Assembly of Signaling Complexes
6.3K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.3K
IP3/DAG Signaling Pathway
13.5K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
13.5K
G Protein-coupled Receptors
15.2K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
15.2K
Transducer Mechanism: G Protein–Coupled Receptors
3.3K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
3.3K
G-protein Coupled Receptors
129.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
129.1K


